ResearcherTulane UniversityActive in the last 2 years

Yaozhong Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-1994-2025; OpenAlex author ID A5025460672. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 2)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 6

Papers, trials and grants by year

2025: 1 paper · 2026: 1 paper

Papers 2

Neoadjuvant therapy-induced remodeling of tumor immune microenvironment in pancreatic ductal adenocarcinoma: a spatial and digital pathology analysis. Last author DOI 10.1007/s00428-025-04056-y ↗
Complement activation in tumor microenvironment after neoadjuvant therapy and its impact on pancreatic cancer outcomes. Last author DOI 10.1038/s41698-025-00848-2 ↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Danting Li · 2 shared papers, 2025–2026 · strength 0.56
- Paper Neoadjuvant therapy-induced remodeling of tumor immune microenvironment in pancreatic ductal adenocarcinoma: a spatial … DOI 10.1007/s00428-025-04056-y ↗
- Paper Complement activation in tumor microenvironment after neoadjuvant therapy and its impact on pancreatic cancer outcomes. DOI 10.1038/s41698-025-00848-2 ↗
Venu Gopal Pillarisetty · 2 shared papers, 2025–2026 · strength 0.56
- Paper Neoadjuvant therapy-induced remodeling of tumor immune microenvironment in pancreatic ductal adenocarcinoma: a spatial … DOI 10.1007/s00428-025-04056-y ↗
- Paper Complement activation in tumor microenvironment after neoadjuvant therapy and its impact on pancreatic cancer outcomes. DOI 10.1038/s41698-025-00848-2 ↗
Xiaofei Zhang · 1 shared paper, 2025 · strength 0.21
- Paper Complement activation in tumor microenvironment after neoadjuvant therapy and its impact on pancreatic cancer outcomes. DOI 10.1038/s41698-025-00848-2 ↗
Michael Shusterman · 1 shared paper, 2025 · strength 0.21
- Paper Complement activation in tumor microenvironment after neoadjuvant therapy and its impact on pancreatic cancer outcomes. DOI 10.1038/s41698-025-00848-2 ↗
Jessica L. Widmer · 1 shared paper, 2025 · strength 0.21
- Paper Complement activation in tumor microenvironment after neoadjuvant therapy and its impact on pancreatic cancer outcomes. DOI 10.1038/s41698-025-00848-2 ↗
John Allendorf · 1 shared paper, 2025 · strength 0.21
- Paper Complement activation in tumor microenvironment after neoadjuvant therapy and its impact on pancreatic cancer outcomes. DOI 10.1038/s41698-025-00848-2 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.